[A25-02] Insulin icodec (type 1 diabetes mellitus) – Addendum to Project A24-90
Last updated 20.02.2025
Project no.:
A25-02
Commission:
Commission awarded on 07.01.2025 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Digestion, metabolism and hormones
Indication:
Adult patients with type 1 diabetes mellitus
Result of dossier assessment:
Unchanged after addendum: added benefit not proven
Note:
If the need for additional work on a project commissioned by the G-BA arises during consultations, then IQWiG presents a report in the form of an "addendum". The G-BA subsequently decides on the extent of the added benefit, thus completing the early benefit assessment.
DOI:
https://doi.org/10.60584/A25-02_en
| Project no. | Title | Status |
|---|---|---|
| A24-90 | Insulin icodec (type 1 diabetes mellitus) – Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
2025-02-20 A G-BA decision was published.